Rigacci, Luigi
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.015
EU - Europa 1.751
AS - Asia 1.189
SA - Sud America 121
AF - Africa 44
Continente sconosciuto - Info sul continente non disponibili 43
OC - Oceania 13
Totale 6.176
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.960
RU - Federazione Russa 697
SG - Singapore 355
IT - Italia 329
CN - Cina 267
HK - Hong Kong 207
PL - Polonia 198
IE - Irlanda 139
VN - Vietnam 114
SE - Svezia 99
BR - Brasile 97
DE - Germania 82
KR - Corea 80
FI - Finlandia 49
IN - India 48
FR - Francia 43
CH - Svizzera 42
CA - Canada 39
JO - Giordania 30
GB - Regno Unito 28
JP - Giappone 21
ID - Indonesia 14
AU - Australia 13
ZA - Sudafrica 11
TR - Turchia 10
BD - Bangladesh 9
NL - Olanda 9
AR - Argentina 7
IQ - Iraq 7
AT - Austria 6
CI - Costa d'Avorio 6
MA - Marocco 6
MX - Messico 6
PK - Pakistan 6
UA - Ucraina 6
CO - Colombia 5
EG - Egitto 5
NG - Nigeria 5
TN - Tunisia 5
VE - Venezuela 5
LT - Lituania 4
EC - Ecuador 3
PT - Portogallo 3
RO - Romania 3
UZ - Uzbekistan 3
BE - Belgio 2
BJ - Benin 2
DK - Danimarca 2
ES - Italia 2
GR - Grecia 2
GT - Guatemala 2
JM - Giamaica 2
OM - Oman 2
PH - Filippine 2
SV - El Salvador 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BO - Bolivia 1
CL - Cile 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
IR - Iran 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
MQ - Martinica 1
MU - Mauritius 1
MY - Malesia 1
NO - Norvegia 1
PS - Palestinian Territory 1
PY - Paraguay 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 6.133
Salva come PNG Salva come JPEG
Città #
Santa Clara 648
Ashburn 431
Singapore 236
Fairfield 204
Warsaw 195
Hong Kong 172
San Jose 157
Chandler 141
Dublin 139
Seattle 124
Woodbridge 101
Cambridge 91
Houston 89
Seoul 78
Beijing 76
Milan 74
Wilmington 73
Ann Arbor 49
Munich 44
Bern 41
Ho Chi Minh City 41
Buffalo 40
Los Angeles 40
Lawrence 38
Altamura 37
Florence 37
Council Bluffs 34
Princeton 33
Hanoi 32
Moscow 31
Lauterbourg 27
Hefei 26
Mumbai 25
Boston 23
Kent 23
Dallas 22
The Dalles 21
Tokyo 21
Helsinki 19
Rome 19
San Diego 18
Shanghai 18
New York 16
Boardman 15
Clifton 13
Lappeenranta 13
Medford 13
Melbourne 12
Bologna 11
Bremen 10
Johannesburg 10
Paris 10
Frankfurt am Main 9
Montreal 9
Norwalk 9
Orem 9
Phoenix 9
Toronto 9
Jakarta 8
Tianjin 8
Guangzhou 7
London 7
Naples 7
São Paulo 7
Washington 7
Abidjan 6
Chennai 6
Dong Ket 6
Falkenstein 6
Hải Dương 6
Redondo Beach 6
Turku 6
Amsterdam 5
Bari 5
Chicago 5
Denver 5
Jacksonville 5
Salerno 5
Sesto Fiorentino 5
Amman 4
Dearborn 4
Falls Church 4
Figino 4
Miami 4
Pune 4
Stockholm 4
Abuja 3
Andover 3
Baghdad 3
Bengaluru 3
Brooklyn 3
Casablanca 3
Cerea 3
Charlotte 3
Chengdu 3
Curitiba 3
Da Nang 3
Izmir 3
Latina 3
Lucca 3
Totale 4.163
Salva come PNG Salva come JPEG
Nome #
Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience 318
MYC protein expression scoring and its impact on the prognosis of aggressive B-cell lymphoma patients 267
Clinical characteristics of interim-PET negative patients with a positive end PET from the prospective HD08-01 FIL study 265
Baseline metabolic tumor volume calculation using different SUV thresholding methods in Hodgkin lymphoma patients: Interobserver agreement and reproducibility across software platforms 258
The ion channels and transporters gene expression profile indicates a shift in excitability and metabolisms during malignant progression of Follicular Lymphoma 243
Nonpeghylated liposomal doxorubicin combination regimen (R-COMP) for the treatment of lymphoma patients with advanced age or cardiac comorbidity 217
Identification Of Pharmacogenomic Markers Of Clinical Efficacy In A Dose-Dense Therapy Regimen (R-Chop14) In Diffuse Large B Cell Lymphoma 210
THE IMPACT OF GENETIC POLYMORPHISMS ON R-CHOP EFFICACY IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: AN INTERIM ANALYSIS OF A MULTICENTER PROSPECTIVE PHARMACOGENETIC STUDY 207
Role of core needle biopsy in primary breast lymphoma 206
Evaluation of the prognostic role of tumour-associated macrophages in newly diagnosed classical Hodgkin lymphoma and correlation with early FDG-PET assessment 204
Focal spleen lesions in visceral leishmaniasis, a neglected manifestation of a neglected disease: report of three cases and systematic review of literature 202
A gene expression-based model to predict metabolic response after two courses of ABVD in Hodgkin Lymphoma patients 201
Role of Genetic Polymorphisms on Response to R-CHOP regimen in Diffuse Large B-cell Lymphoma Patients: an Interim Analysis of a Multicenter Prospective Pharmacogenetic Study 200
Diffusion-Weighted and Perfusion-Weighted MRI to Evaluate Therapeutic Response in Lymphoma: A Comparison with FDG-PET/CT 198
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 196
Evidence for reduced angiogenesis in bone marrow in SSc: immunohistochemistry and multiparametric computerized imaging analysis. 196
CLINICAL CHARACTERISTICS OF PATIENTS WITH NEGATIVE INTERIM-PET AND POSITIVE FINAL PET: DATA FROM THE PROSPECTIVE PET-ORIENTED HD0801 STUDY BY FONDAZIONE ITALIANA LINFOMI (FIL) 196
Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma 195
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 184
Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: A report from the ITA-HEMA-COV 179
Feasibility and safety of a reduced duration of therapy of colony-stimulating factor in a dose-dense regimen 178
Romiplostim before splenectomy in a patient with aggressive non-Hodgkin lymphoma and poor response to platelet transfusions 177
Aggressive Disease Course of Multiple Myeloma with Concomitant ALK-Negative Anaplastic Large Cell Lymphoma: A Case Report with an Unusual Presentation 174
The prognostic value of positron emission tomography performed after two courses (INTERIM-PET) of standard therapy on treatment outcome in early stage Hodgkin lymphoma: A multicentric study by the fondazione italiana linfomi (FIL) 171
Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study. 154
Pharmacogenomic Markers of Clinical Efficacy in a Dose-Dense Therapy Regimen (R-CHOP14) in Diffuse Large B Cell Lymphoma 152
CMV AND EBV REACTIVATION AFTER AUTOLOGOUS HAEMOPOIETIC STEM CELL TRANSPLANTATION WITH BEAM CONDITIONING REGIMEN FOR MULTIPLE SCLEROSIS AND LYMPHOMA: A RETROSPECTIVE SINGLE CENTER CASE-CONTROL STUDY 151
Treatment and prognosis of primary pulmonary lymphoma: a long-term follow-up study 145
Pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B cell lymphoma: preliminary results 135
In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles 134
Single dose palonosetron and dexamethasone in preventing nausea and vomiting induced by high emetogenic ABVD regimen in Hodgkin Lymphoma patients. 133
In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles 130
Totale 6.176
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.371
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.371
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022229 0 0 29 17 9 10 14 20 21 11 38 60
2022/2023662 47 120 36 45 37 105 80 43 84 7 11 47
2023/2024296 7 29 34 7 35 38 6 72 7 18 32 11
2024/20251.822 54 180 108 343 529 266 16 84 73 44 60 65
2025/20261.869 262 225 111 136 242 60 268 87 108 131 34 205
2026/2027161 50 36 75 0 0 0 0 0 0 0 0 0
Totale 6.176